As a biopharma expert with a deep background in research and technology, Ivan Kairatov has a unique perspective on the intersection of artificial intelligence and frontline medicine. His work focuses on how innovations like causal modeling can translate complex data into life-saving actions. Today,
The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would
Today we’re speaking with Ivan Kairatov, a biopharma expert with a deep understanding of how technology and innovation are reshaping the industry. We'll be exploring the fascinating and complex gap between the theoretical promise of AI in medicine and its real-world performance. The conversation
The quiet aftermath of a traumatic event often conjures images of panicked awakenings and a constant state of high alert, yet for the vast majority of survivors, the most debilitating struggle is a silent, internal battle waged not against terror but against a crushing weight of sorrow and
The persistent link between a stressful week and an unwelcome skin breakout, or the way certain meals can either energize the mind or cast a fog over it, is far more than mere coincidence. These everyday experiences are surface-level indicators of a profound and constant dialogue happening deep
As a biopharma expert deeply involved in technological innovation, Ivan Kairatov has been at the forefront of applying advanced science to solve critical industry challenges. Today, he joins us to discuss a groundbreaking development in food safety: an artificial intelligence system that
